| Exposure to low-dose ionizing radiation from medical imaging procedures R Fazel, HM Krumholz, Y Wang, JS Ross, J Chen, HH Ting, ND Shah, ... New England Journal of Medicine 361 (9), 849-857, 2009 | 1639 | 2009 |
| Diagnoses and timing of 30-day readmissions after hospitalization for heart failure, acute myocardial infarction, or pneumonia K Dharmarajan, AF Hsieh, Z Lin, H Bueno, JS Ross, LI Horwitz, ... Jama 309 (4), 355-363, 2013 | 1207 | 2013 |
| Trends in length of stay and short-term outcomes among Medicare patients hospitalized for heart failure, 1993-2006 H Bueno, JS Ross, Y Wang, J Chen, MT Vidán, SLT Normand, JP Curtis, ... Jama 303 (21), 2141-2147, 2010 | 859 | 2010 |
| An administrative claims measure suitable for profiling hospital performance on the basis of 30-day all-cause readmission rates among patients with heart failure PS Keenan, SLT Normand, Z Lin, EE Drye, KR Bhat, JS Ross, JD Schuur, ... Circulation: Cardiovascular Quality and Outcomes 1 (1), 29-37, 2008 | 590 | 2008 |
| Recent national trends in readmission rates after heart failure hospitalization JS Ross, J Chen, Z Lin, H Bueno, JP Curtis, PS Keenan, SLT Normand, ... Circulation: Heart Failure 3 (1), 97-103, 2010 | 586 | 2010 |
| Guest authorship and ghostwriting in publications related to rofecoxib: a case study of industry documents from rofecoxib litigation JS Ross, KP Hill, DS Egilman, HM Krumholz Jama 299 (15), 1800-1812, 2008 | 577 | 2008 |
| Recent trends in chronic disease, impairment and disability among older adults in the United States WW Hung, JS Ross, KS Boockvar, AL Siu BMC geriatrics 11, 1-12, 2011 | 480 | 2011 |
| Trial publication after registration in ClinicalTrials. Gov: a cross-sectional analysis JS Ross, GK Mulvey, EM Hines, SE Nissen, HM Krumholz PLoS medicine 6 (9), e1000144, 2009 | 470 | 2009 |
| Potential overtreatment of diabetes mellitus in older adults with tight glycemic control KJ Lipska, JS Ross, Y Miao, ND Shah, SJ Lee, MA Steinman JAMA internal medicine 175 (3), 356-362, 2015 | 460 | 2015 |
| Statistical models and patient predictors of readmission for heart failure: a systematic review JS Ross, GK Mulvey, B Stauffer, V Patlolla, SM Bernheim, PS Keenan, ... Archives of internal medicine 168 (13), 1371-1386, 2008 | 456 | 2008 |
| Clinical trial evidence supporting FDA approval of novel therapeutic agents, 2005-2012 NS Downing, JA Aminawung, ND Shah, HM Krumholz, JS Ross Jama 311 (4), 368-377, 2014 | 452 | 2014 |
| Relationship between hospital readmission and mortality rates for patients hospitalized with acute myocardial infarction, heart failure, or pneumonia HM Krumholz, Z Lin, PS Keenan, J Chen, JS Ross, EE Drye, ... Jama 309 (6), 587-593, 2013 | 446 | 2013 |
| National trends in US hospital admissions for hyperglycemia and hypoglycemia among Medicare beneficiaries, 1999 to 2011 KJ Lipska, JS Ross, Y Wang, SE Inzucchi, K Minges, AJ Karter, ES Huang, ... JAMA internal medicine 174 (7), 1116-1124, 2014 | 445 | 2014 |
| Publication of NIH funded trials registered in ClinicalTrials. gov: cross sectional analysis JS Ross, T Tse, DA Zarin, H Xu, L Zhou, HM Krumholz Bmj 344, 2012 | 442 | 2012 |
| What have we learnt from Vioxx? HM Krumholz, JS Ross, AH Presler, DS Egilman Bmj 334 (7585), 120-123, 2007 | 380 | 2007 |
| Hospital volume and 30-day mortality for three common medical conditions JS Ross, SLT Normand, Y Wang, DT Ko, J Chen, EE Drye, PS Keenan, ... New England Journal of Medicine 362 (12), 1110-1118, 2010 | 356 | 2010 |
| Trends in drug utilization, glycemic control, and rates of severe hypoglycemia, 2006–2013 KJ Lipska, X Yao, J Herrin, RG McCoy, JS Ross, MA Steinman, ... Diabetes care 40 (4), 468-475, 2017 | 347 | 2017 |
| Association of use of an intravascular microaxial left ventricular assist device vs intra-aortic balloon pump with in-hospital mortality and major bleeding among patients with … SS Dhruva, JS Ross, BJ Mortazavi, NC Hurley, HM Krumholz, JP Curtis, ... Jama 323 (8), 734-745, 2020 | 343 | 2020 |
| Reduction in acute myocardial infarction mortality in the United States: risk-standardized mortality rates from 1995-2006 HM Krumholz, Y Wang, J Chen, EE Drye, JA Spertus, JS Ross, JP Curtis, ... Jama 302 (7), 767-773, 2009 | 340 | 2009 |
| Postmarket safety events among novel therapeutics approved by the US Food and Drug Administration between 2001 and 2010 NS Downing, ND Shah, JA Aminawung, AM Pease, JD Zeitoun, ... Jama 317 (18), 1854-1863, 2017 | 310 | 2017 |
Harlan KrumholzYale UniversityBestätigte E-Mail-Adresse bei yale.edu